DimiCare Biotech
PrivateLast Round
Grant
Nov 17, 2025
Company Overview
DimiCare Biotech is a biopharmaceutical company developing precision antibiotics to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DimiCare Biotech Comparables
Compare DimiCare Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pylum Biosciences, Inc. | 81% | |
| Glox Therapeutics | 80% | |
| Hsiri Therapeutics | 78% | |
DimiCare Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 17, 2025 |
DimiCare Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| SATT Sud-Est | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 182% MoM.
DimiCare Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DimiCare Biotech's valuation, stock price, and market status.